Rodrigo Pessoa Cavalcanti Lira Selected Research

Open-Angle Glaucoma (Glaucoma, Open Angle)

1/2021

TXNRD2 (rs35934224) CT genotype as possible protective marker for primary open-angle glaucoma in a Brazilian population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rodrigo Pessoa Cavalcanti Lira Research Topics

Disease

6	Cataract (Cataracts) 01/2022 - 03/2005
2	Retinal Perforations 01/2024 - 06/2021
2	Surgical Wound 01/2021 - 04/2018
2	Hypersensitivity (Allergy) 04/2018 - 07/2007
2	Hypertension (High Blood Pressure) 07/2007 - 03/2005
1	HIV Infections (HIV Infection) 03/2023
1	Endophthalmitis (Ophthalmia) 01/2022
1	Epiretinal Membrane (Epiretinal Membranes) 06/2021
1	Corneal Ulcer 02/2021
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2021
1	Refractive Errors (Refractive Error) 11/2020
1	Choroid Diseases 11/2020
1	Zika Virus Infection 11/2016
1	Atrophy 11/2016
1	Viral Conjunctivitis 09/2015
1	Conjunctivitis 09/2015
1	Foreign Bodies (Foreign Body) 09/2015
1	Pruritus (Itching) 09/2015
1	Toxoplasmosis 04/2014
1	Optic Neuritis (Retrobulbar Neuritis) 11/2012
1	Mydriasis 07/2012
1	Esotropia (Esophoria) 01/2011
1	Strabismus (Squint) 01/2011
1	Exotropia (Exophoria) 01/2011
1	Retinal Detachment (Retinal Detachments) 12/2010
1	Retinal Degeneration 11/2010
1	Pain (Aches) 11/2010
1	Telangiectasis (Telangiectasia) 08/2010
1	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2008
1	Eye Infections 11/2007
1	Nausea 01/2007
1	Cysts 09/2006
1	Intraoperative Complications 04/2003
1	Myocardial Infarction 04/2003

Drug/Important Bio-Agent (IBA)

3	Retinaldehyde (Retinal)IBA 03/2023 - 11/2016
2	Fluorescein (Funduscein)FDA LinkGeneric 07/2007 - 01/2007
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	NicergolineIBA 02/2021
1	Thioredoxin Reductase 2IBA 01/2021
1	Nylons (Nylon)IBA 01/2021
1	Polyglactin 910IBA 01/2021
1	Moxifloxacin (Avelox)FDA Link 04/2018
1	QuinolonesIBA 04/2018
1	Povidone-Iodine (Betadine)FDA LinkGeneric 09/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 09/2015
1	Lubricant Eye Drops (Artificial Tears)IBA 09/2015
1	Povidone (Crospovidone)IBA 09/2015
1	Ophthalmic Solutions (Eye Drops)IBA 09/2015
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 04/2014
1	Methylprednisolone FDA LinkGeneric 11/2012
1	nepafenac (Nevanac)FDA Link 07/2012
1	Prednisolone (Predate)FDA LinkGeneric 07/2012
1	prednisolone acetate FDA LinkGeneric 07/2012
1	KetorolacIBA 07/2012
1	Ketorolac Tromethamine (Acular)FDA LinkGeneric 07/2012
1	Type A Botulinum Toxins (Botox)FDA Link 01/2011
1	Ranibizumab (Lucentis)FDA Link 08/2010
1	Coloring Agents (Dyes)IBA 07/2007
1	bromoprideIBA 01/2007
1	Glucose (Dextrose)FDA LinkGeneric 03/2005
1	Blood Glucose (Blood Sugar)IBA 04/2003
1	Hemoglobins (Hemoglobin)IBA 04/2003

Therapy/Procedure

4	Vitrectomy 01/2024 - 09/2006
3	Light Coagulation 12/2010 - 01/2008
3	Lasers (Laser) 12/2010 - 01/2008
1	Intracameral Injection 01/2022
1	Sutures (Suture) 01/2021
1	Cryotherapy (Therapy, Cold) 12/2010
1	Eyeglasses (Spectacles) 11/2007
1	Local Anesthesia 03/2005
1	General Anesthesia 04/2003